Skip to main content

Month: June 2022

Legion Capital Announces 2021 Financial Results

FinTech driven Specialized Lender reports first full year of profitability ORLANDO, Fla., June 17, 2022 (GLOBE NEWSWIRE) — Legion Capital (OTC:LGCP), a FinTech driven, specialized business lender providing growth capital to small and medium sized companies and real estate developers, today announced audited financial results for its fiscal year 2021 ended December, 2021. Highlights from the 1-K annual report filed today are:The Company reported its first annual profit since inception, with reported profit of $279,600 compared to reported losses of $2,880,231 in 2020.The Company ended the year with $16,898,222 of cash, compared with $1,227,094 in 2020, a 1,277% increase.Revenue increased from $2,350,295 in 2020 to $3,265,718 in 2021, a 39% increase.Shareholder equity increased from $285,125 in 2020 to $10,152,729 in 2021,...

Continue reading

HEXO Acknowledges Zenabis Group CCAA Filing

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. GATINEAU, Quebec, June 17, 2022 (GLOBE NEWSWIRE) — HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”) acknowledged today that its wholly-owned subsidiary, Zenabis Global Inc. (“Zenabis”), as well as Zenabis’ direct and indirect wholly-owned subsidiaries (collectively, the “Zenabis Group”), have filed a petition with the Superior Court of Québec for protection under the Companies’ Creditors Arrangement Act (“CCAA”) in order to restructure their business and financial affairs. HEXO understands that Ernst & Young Inc. has been appointed as the Monitor to oversee the CCAA proceedings. The...

Continue reading

Irwin Naturals Expands Operations into Northeast with Acquisition of Vermont-Based Clinic

Company continues national growth trajectory for Emergence clinics focusing on total wellness including the therapeutic use of ketamine LOS ANGELES, June 17, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has entered into a binding agreement to acquire the assets of Hobie Fuerstman D O PLC, doing business as Preventive Medicine (“Preventive”), a clinic operation based in Colchester, Vermont. Klee Irwin, CEO of Irwin Naturals, said, “Our roll-up is gathering momentum. This is the eighth ketamine clinic we are adding to our growing portfolio, which now covers four states, made up of acquired clinics and clinics under definitive agreements. Our mission is to make this amazingly effective treatment available and accessible throughout the country and beyond,...

Continue reading

Board of Directors

Octopus Titan VCT plc  Board of Directors As announced on 21 April 2022 as part of the annual results, the Board confirms that John Hustler retired from the Board following the AGM held on 14 June 2022. Tom Leader has taken over as Chair of the Company and Lord Rockley is now Chair of the Audit Committee.For further information please contact: Rachel Peat Octopus Company Secretarial Services Limited Tel: +44 (0)80 0316 2067LEI: 213800A67IKGG6PVYW75

Continue reading

Condor Gold Closes Previously Announced Private Placement of Units for Aggregate Gross Proceeds of £3.25 Million

LONDON, June 17, 2022 (GLOBE NEWSWIRE) — Condor Gold (AIM: CNR; TSX: COG) is pleased to announce the closing of its previously announced placing of 11,607,149 units of the Company (“Units”) at a price of 28p per Unit (the “Placing”), including a Directors subscription of 1,833,573 Units, for aggregate gross proceeds of £3.25 million before expenses (the “Proceeds”). Each Unit is comprised of one ordinary share of 20p each in the Company (each, an “Ordinary Share”) and one-half of one Ordinary Share purchase warrant (each whole Ordinary Share purchase warrant, a “Warrant”). Each Warrant, which is unlisted and fully transferable, entitles the holder thereof to purchase one Ordinary Share at a price of 35p for a period of 36 months from the date on which the shares are issued pursuant to the Placing. The Proceeds have been received...

Continue reading

Quotient Limited to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd

JERSEY, Channel Islands, June 17, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2022 will be released before market open on Wednesday, June 22, 2022.Title:Quotient Fourth Quarter and Full Year 2021 Financial Results and Conference Call   Speakers: Manuel O. Méndez, Chief Executive OfficerAli J. Kiboro, Chief Financial Officer   Date: Wednesday, June 22, 2022Time: 8:00am ET/ 14:00 CET   Conference CallDial-in Details: International: 201-689-8560Switzerland: 0800 835 525United Kingdom: 0800 756 3429US: 877-407-0784Conference ID: 13729874   Webcast: Webcast Link – Click HereQuotient Events & PresentationsThe webcast should be accessed 15...

Continue reading

MRC Global Announces Second Quarter 2022 Earnings Release and Conference Call Schedule

HOUSTON, June 17, 2022 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC) will release its second quarter 2022 results on August 8, 2022, after the market closes. In conjunction with the release, the company will host a conference call, which will be webcast, on Tuesday, August 9, 2022, at 10:00 a.m. Eastern / 9:00 a.m. Central.What: MRC Global Second Quarter 2022 Earnings Conference Call   When: Tuesday, August 9, 2022, at 10:00 a.m. Eastern / 9:00 a.m. Central   How: Via phone — Dial 201-689-8261 and ask for the MRC Global call at least 10 minutes prior to the start time, or via webcast — at http://www.mrcglobal.comA replay will be available through August 23, 2022, by dialing 201-612-7415 using passcode 13730617#. An archive of the webcast will be available shortly after the call at www.mrcglobal.com...

Continue reading

Radisson announces results of its Annual General Meeting of Shareholders

ROUYN-NORANDA, Quebec, June 17, 2022 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTC: RMRDF): (“Radisson” or the “Company) is pleased to announce the results of its Annual General Meeting of Shareholders (“AGM”) held in Rouyn-Noranda, Qc on June 16, 2022. Shareholders voted in favour of all items of business, including the election of each director nominee. A total of 68,399,366 votes were represented in the meeting amounting to 24.82% of the issued common class A share shares as of the record date. All votes were submitted by proxy with the following tabulation of these votes:Directors Tabulation of Votes in Favour submitted by Proxy Tabulation of Votes Withheld submitted by ProxyDenis Lachance 67,108,082 (99.07%) 627,647 (0.01%)Denis Bois 67,732,582 (100.00%) 3,147 (0.02%)Pierre Beaudoin 67,679,332...

Continue reading

Results of the private placement of AT1 notes of Coop Pank AS

The Management Board of Coop Pank AS approved the allocation of the private placement of notes qualifying as Additional Tier 1 (AT1) own funds of the bank, according to which 161 notes with nominal value 100,000 EUR each are allocated to in total 42 investors. The total value of the issue is 16,1 EUR. Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The bank has 128 300 clients who use everyday banking services. Coop Pank uses the synergy created between retail trade and banking and brings everyday banking solutions closer to people. The majority shareholder of the Bank is a domestic retail chain Coop Eesti, the sales network of which comprises 330 stores. Additional information: Paavo Truu CFO Phone: 5160 231 E-mail: paavo.truu@cooppank.ee Important information Coop Pank AS’s notes qualifying...

Continue reading

Stephen Bardin to Join atai Life Sciences as CFO Designate

Stephen Bardin will join as CFO Designate on June 27, 2022 After a transition period, atai’s current CFO Greg Weaver will be moving into a part time strategic advisory roleNEW YORK and BERLIN, June 17, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V., (Nasdaq: ATAI) (“atai” or the “Company”), a clinical stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced today that Stephen Bardin, currently Senior Vice President of Finance and Operations at BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), will be appointed Chief Financial Officer during the third quarter of 2022. Initially, Mr. Bardin will join the Company as Deputy CFO and CFO Designate on June 27th and will be supported in his transition by current CFO Greg Weaver. Mr. Weaver, after two years of exceptional...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.